Literature DB >> 9339753

Varicella vaccination in children after bone marrow transplantation.

A Sauerbrei1, J Prager, U Hengst, F Zintl, P Wutzler.   

Abstract

Herpes zoster (HZ) is one of the most common complications after bone marrow transplantation (BMT) in children. Apart from treatment with antiviral drugs, effective prevention by active immunization with varicella-zoster virus (VZV) appears to be possible. In this study 15 patients were vaccinated with a live attenuated VZV vaccine (Varilrix) 12-23 months after BMT. The vaccine was well tolerated without adverse reactions. Chickenpox or HZ were not observed for up to 2 years after immunization. Eight out of nine seronegative patients seroconverted and in six virus-specific IgG could still be demonstrated 2 years later. The incidence of VZV diseases in 133 non-immunized children after BMT was 26.3%. Infections usually occurred within 18 months after BMT.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9339753     DOI： 10.1038/sj.bmt.1700909

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  8 in total

1.  Live virus vaccines in transplantation: friend or foe?

Authors:  Charlotte M Verolet; Klara M Posfay-Barbe
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

2.  Zoster prophylaxis after allogeneic hematopoietic cell transplantation using acyclovir/valacyclovir followed by vaccination.

Authors:  Kareem Jamani; Judy MacDonald; Martin Lavoie; Tyler S Williamson; Christopher B Brown; Ahsan Chaudhry; Victor H Jimenez-Zepeda; Peter Duggan; Jason Tay; Douglas Stewart; Andrew Daly; Jan Storek
Journal:  Blood Adv       Date:  2016-11-30

3.  Safety and immunogenicity of the live attenuated varicella vaccine following T replete or T cell-depleted related and unrelated allogeneic hematopoietic cell transplantation (alloHCT).

Authors:  Joanne F Chou; Nancy A Kernan; Susan Prockop; Glenn Heller; Andromachi Scaradavou; Rachel Kobos; Molly A Knowles; Esperanza B Papadopoulos; Anne Casson; Catherine Copeland; Joanne Torok-Castanza; Nicole Zakak; Julianne Ruggiero; Trudy N Small
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-23       Impact factor: 5.742

4.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Authors:  Nancy Bunin; Trudy Small; Paul Szabolcs; K Scott Baker; Michael A Pulsipher; Troy Torgerson
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

5.  Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation.

Authors:  Avinash K Shetty; Mary A Winter
Journal:  Ochsner J       Date:  2012

6.  The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.

Authors:  Ryo Shimizu; Chikako Ohwada; Yuhei Nagao; Emi Togasaki; Chika Kawajiri; Tomoya Muto; Shokichi Tsukamoto; Shio Sakai; Yusuke Takeda; Naoya Mimura; Masahiro Takeuchi; Emiko Sakaida; Tohru Iseki; Chiaki Nakaseko
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

7.  Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease.

Authors:  Huyen-Tran Nguyen; Phillip Minar; Kimberly Jackson; Patricia C Fulkerson
Journal:  World J Gastroenterol       Date:  2017-11-14       Impact factor: 5.742

8.  Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.

Authors:  Andrew J Ullmann; Martin Schmidt-Hieber; Hartmut Bertz; Werner J Heinz; Michael Kiehl; William Krüger; Sabine Mousset; Stefan Neuburger; Silke Neumann; Olaf Penack; Gerda Silling; Jörg Janne Vehreschild; Hermann Einsele; Georg Maschmeyer
Journal:  Ann Hematol       Date:  2016-06-24       Impact factor: 3.673
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.